In this article, we are going to take a look at where Zymeworks Inc. (NASDAQ:ZYME) stands against other stocks that insiders bought in April after Trump’s tariff rollout. President Donald Trump ...

VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...

$ZYME insiders have traded $ZYME stock on the open market 27 times in the past 6 months. Of those trades, 22 have been purchases and 5 have been sales. Here’s a ...

Zymeworks Inc. (ZYME) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.20 per share a year ago. These figures ...

Short interest in Zymeworks Inc (NASDAQ:ZYME) decreased during the last reporting period, falling from 5.42M to 5.41M. This put 10.09% of the company's publicly available shares short. Short ...